APA (7th ed.) Citation

Ye, Z., Dai, W., Zhang, S., Xiang, Y., Wang, J., Zhang, Y., . . . Zhang, L. (2026). A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models. PLoS Pathogens, 22(3), 1. https://doi.org/10.1371/journal.ppat.1014051

Chicago Style (17th ed.) Citation

Ye, Zhengyu, et al. "A Clinical SARS-CoV-2 Mpro Inhibitor Blocks Replication of Multiple Enteroviruses and Confers Oral in Vivo Protection in Animal Models." PLoS Pathogens 22, no. 3 (2026): 1. https://doi.org/10.1371/journal.ppat.1014051.

MLA (9th ed.) Citation

Ye, Zhengyu, et al. "A Clinical SARS-CoV-2 Mpro Inhibitor Blocks Replication of Multiple Enteroviruses and Confers Oral in Vivo Protection in Animal Models." PLoS Pathogens, vol. 22, no. 3, 2026, p. 1, https://doi.org/10.1371/journal.ppat.1014051.